Blocking the immune checkpoint PD-L1 or PD-1 allows for the T cell killing of tumor cells, and immune checkpoint inhibitors targeting the PD-1/PD-L1 interaction have revolutionized modern cancer therapy for advanced cancer [18,31,32,33]. This evidence concerns the gene PDCD1 and cancer.